Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

Rituximab hypersensitivity reactions are rare but are one of the main causes of rituximab elimination from antilymphoma immunochemotherapy treatments. While the clinical picture may be indistinguishable from other infusion-related reactions, hypersensitivity reactions (HSR) do not disappear and inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Novelli, S., Soto, L., Caballero, A., Moreno, M. E., Lara, M. J., Bayo, D., Quintas, A., Jimeno, P., Zamora, M. I., Bigorra, T., Sierra, J., Briones, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305539/
https://www.ncbi.nlm.nih.gov/pubmed/32577119
http://dx.doi.org/10.1155/2020/4231561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305539/
https://www.ncbi.nlm.nih.gov/pubmed/32577119
http://dx.doi.org/10.1155/2020/4231561

Ejemplares similares